Malignancies in the Rheumatoid Arthritis Abatacept Clinical Development Programme: An Epidemiological Assessment

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.2008.097527
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

The Efficacy and Safety of Abatacept in Rheumatoid Arthritis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2010English

Experience With Subcutaneous Abatacept for Rheumatoid Arthritis: An Update for Clinicians

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2014English

Effects of Abatacept on Monocytes in Patients With Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

Abatacept: The Evidence for Its Place in the Treatment of Rheumatoid Arthritis

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Efficacy, Safety, and Tolerability of Abatacept in the Management of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2009English

P018 Anti-Carbamylated Protein Antibodies as a Clinical Response Predictor in Rheumatoid Arthritis Patients Treated With Abatacept

2019English

Disease Assessment in Rheumatoid Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1989English

Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of Up to 8 Years of Treatment From the Abatacept Clinical Trial Program

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

Abatacept: A T-Cell Co-Stimulation Modulator for the Treatment of Rheumatoid Arthritis

Clinical Rheumatology
MedicineRheumatology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy